DE2512391C2 - Mittel zur Behandlung der Mastitis in Milchtieren - Google Patents

Mittel zur Behandlung der Mastitis in Milchtieren

Info

Publication number
DE2512391C2
DE2512391C2 DE2512391A DE2512391A DE2512391C2 DE 2512391 C2 DE2512391 C2 DE 2512391C2 DE 2512391 A DE2512391 A DE 2512391A DE 2512391 A DE2512391 A DE 2512391A DE 2512391 C2 DE2512391 C2 DE 2512391C2
Authority
DE
Germany
Prior art keywords
mastitis
oil
milk
penicillin
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2512391A
Other languages
German (de)
English (en)
Other versions
DE2512391A1 (de
Inventor
Jack Thaddeus Kalamazoo Mich. Bryan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of DE2512391A1 publication Critical patent/DE2512391A1/de
Application granted granted Critical
Publication of DE2512391C2 publication Critical patent/DE2512391C2/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DE2512391A 1974-03-29 1975-03-21 Mittel zur Behandlung der Mastitis in Milchtieren Expired DE2512391C2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45603074A 1974-03-29 1974-03-29

Publications (2)

Publication Number Publication Date
DE2512391A1 DE2512391A1 (de) 1975-10-02
DE2512391C2 true DE2512391C2 (de) 1986-10-09

Family

ID=23811160

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2512391A Expired DE2512391C2 (de) 1974-03-29 1975-03-21 Mittel zur Behandlung der Mastitis in Milchtieren

Country Status (8)

Country Link
BE (1) BE827361A (cs)
CA (1) CA1052697A (cs)
DE (1) DE2512391C2 (cs)
DK (1) DK143438C (cs)
FR (1) FR2265408B1 (cs)
GB (1) GB1456349A (cs)
NL (1) NL7502808A (cs)
ZA (1) ZA751451B (cs)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1547164A (en) * 1975-08-14 1979-06-06 Beecham Group Ltd Veterinary compositions
IT1190445B (it) * 1985-11-08 1988-02-16 Fatro Spa Composizioni veterinarie a base di agenti antimicrobici e loro impiego
SE457693B (sv) * 1986-07-01 1989-01-23 Drilletten Ab Komposition med reglerad frigoering vari ett biologiskt material aer loest eller dispergerat i en l2-fas
DK16290D0 (da) * 1990-01-19 1990-01-19 Spindel & Spinnfluegelfab Veb Pattebehandlingsmiddel navnlig til bekaempelse af mastitis
GB2273443B (en) * 1992-12-08 1997-01-08 Bimeda Res Dev Ltd Veterinary composition for the treatment of mastitis
CA2264286A1 (en) * 1996-09-06 1998-03-12 Minnesota Mining And Manufacturing Company Antimicrobial compositions
CA2274796C (en) 1996-12-18 2006-12-05 Bimeda Research & Development Limited Antiinfective free intramammary veterinary composition
FR2833500A1 (fr) * 2001-12-17 2003-06-20 Veyron Et Froment Lab Gel huileux anhydre stabilise
NZ519112A (en) * 2002-05-22 2004-12-24 Interag Drug delivery device for administration of active agent to mammary gland cavity
US7842791B2 (en) 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions
US20040197422A1 (en) * 2002-12-20 2004-10-07 Pfizer Inc Veterinary compositions for treating mastitis
GB0229642D0 (en) * 2002-12-20 2003-01-22 Pfizer Ltd Veterinary compositions for treating mastitis
BRPI0507279A (pt) 2004-02-02 2007-06-26 Bimeda Res & Dev Ltd método e dispositivo para o tratamento do canal da teta de um animal
NZ548748A (en) 2004-02-02 2010-09-30 Bimeda Res & Dev Ltd Method and device for treating a teat canal of an animal
EP2079477B1 (en) 2006-10-10 2017-07-26 Wisconsin Alumni Research Foundation Intra-mammary teat sealant formulation and method of using same to reduce or eliminate visual defects in aged cheeses
AU2010234514B2 (en) * 2009-04-08 2014-03-27 Wisconsin Alumni Research Foundation Intra-mammary teat sealant formulation and method of using same to reduce or eliminate visual defects in aged cheeses

Also Published As

Publication number Publication date
NL7502808A (nl) 1975-10-01
DE2512391A1 (de) 1975-10-02
FR2265408B1 (cs) 1978-08-04
DK143438C (da) 1981-12-21
CA1052697A (en) 1979-04-17
FR2265408A1 (cs) 1975-10-24
GB1456349A (en) 1976-11-24
AU7909675A (en) 1976-09-16
ZA751451B (en) 1976-02-25
DK106175A (cs) 1975-09-30
DK143438B (da) 1981-08-24
BE827361A (fr) 1975-09-29

Similar Documents

Publication Publication Date Title
DE2512391C2 (de) Mittel zur Behandlung der Mastitis in Milchtieren
DE60317662T2 (de) Zusammensetzungen und verfahren zur behandlung von infektionen bei vieh und schweinen
DE3752217T2 (de) Topische antimikrobielle Arzneimittel
DE3888504T2 (de) Behandlung von Mastitis und Appliziereinrichtung dafür.
DE2635476C2 (de) Tierarzneimittel
DE69728783T2 (de) Verbesserte arzneimittel
DE69000663T2 (de) Oral verabreichbarer calciumzusatz fuer vieh.
DE60305728T2 (de) Pharmazeutische Zusammensetzung mit verlängerter Freisetzung
DE2802273C3 (de) Verfahren zur Herstellung von Suppositorien aus Aminoglycid-Antibiotica
DE60320034T2 (de) Behandlung von mastitis mit einer kombination aus prednisolon und cephalosporin
DE102004025324A1 (de) Flüssige Zubereitung für die Veterinärmedizin, Verfahren zu deren Herstellung und deren Verwendung
EP0667152A1 (de) Orale Verwendung von Calciumformiat zur Behandlung von Calciumdefizienz bei Tieren
CH664285A5 (de) Synergistisch wirkende arzneimittelkombinationen und verfahren zu ihrer herstellung.
DE2640322A1 (de) Medizinische zubereitung mit einem gehalt an nebennierenrindenhormon und einem ein schilddruesenstimulierendes hormon freisetzenden hormon
DE2929840C2 (cs)
DE3248328A1 (de) Schwerloesliche salze von aminoglykosiden sowie diese enthaltende formulierungen mit verzoegerter wirkstoff-freigabe
DE69730983T2 (de) Nicht-wässriges oral verabreichbares pastenförmiges mittel zur tierärztlichen verwendung, verfahren zu dessen herstellung sowie die verwendung eines öligen trägers zur herstellung eines solchen mittels
DE3104282C2 (cs)
DE960579C (de) Verfahren zur Herstellung eines in der Hitze sterilisierbaren Adrenocorticotropin-Praeparates
DE2612250A1 (de) 4-(5-nitrofuryl)-chinolin-2-carbonsaeure-n-oxid, verfahren zu seiner herstellung und seine verwendung
CH400454A (de) Verfahren zur Herstellung von Lösungen des Chloramphenicols in wässrigen Flüssigkeiten
DE2023547A1 (de) Aminosäuren enthaltende Mischfutter additive für die Fütterung von Wiederkäuern
DE102011081943A1 (de) Pharmazeutische Formulierung zur Behandlung von Mastitis bei Säugern
DE2001671C3 (de) Plyvalentes Mastits-Immunglobulin und dessen Verwendung bei der Bekämpfung der Mastits
DE69718541T2 (de) Veterinäre Zusammensetzungen mit antibakteriellen Mitteln zur intramammären Anwendung

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
D2 Grant after examination
8364 No opposition during term of opposition